V1 Biotech BlackSwanCatcher K-1 Free
Today’s Change (Aug 23, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
A biotech‑first switcher: 2x long (BIB) in healthy uptrends, 2x short (BIS) when biotech is overheated, otherwise rotates into a safety basket (gold, U.S. dollar, and defensive sectors) using simple heat and drawdown checks.
Focus: biotech. It rides uptrends with BIB (a 2x bullish biotech fund) and can short sharp spikes with BIS (a 2x bearish biotech fund). When biotech looks weak or jumpy, it parks in a safety mix: GLD (gold), USDU (long U.S. dollar), and 1–3 sector funds such as XLV (health care), XLU (utilities), XLP (staples). It switches using simple heat checks: stretched vs beaten‑down prices, price vs a short‑term average, big recent drops, and whether bonds are outpacing stocks.
Biotech-driven strategy offers higher out-of-sample upside: ~27% annualized vs SPY ~21%, with a low market beta (~0.67) for diversification. Dynamic long/short biotech plus a gold/USD safety sleeve aims to navigate volatility; larger drawdowns are possible.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.33 | 0.63 | 0.12 | 0.35 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 351.54% | 14.94% | 2.33% | 3.36% | 0.88 | |
| 5,934.59% | 46.05% | 26.82% | 17.21% | 1.34 |
Initial Investment
$10,000.00
Final Value
$603,459.02Regulatory Fees
$3,646.26
Total Slippage
$29,850.85
Invest in this strategy
OOS Start Date
Aug 6, 2023
Trading Setting
Threshold 10%
Type
Stocks
Category
Biotech tactical, leveraged long/short, momentum/mean-reversion, defensive rotation, gold & usd hedges, volatility & drawdown filters